EAPH (Easton Pharmaceuticals) Total Equity: $6.65 Mil (As of Sep. 2021)


EAPH Easton Pharmaceuticals Inc EAPH
12 GF Score
Price $0.00
View Full Analysis

What is Easton Pharmaceuticals Total Equity?

Easton Pharmaceuticals EAPH -95.00% 12 Total Equity is $6.65 Mil as of Sep. 2021. GuruFocus rates EAPH with a GF Score™ of 12/100.

Easton Pharmaceuticals's total equity for the quarter that ended in Sep. 2021 was $6.65 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Easton Pharmaceuticals Total Equity Historical Data

* Premium members only.

The historical data trend for Easton Pharmaceuticals's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Easton Pharmaceuticals Total Equity Chart

Easton Pharmaceuticals Annual Data
Trend Dec01 Dec02 Dec03 Dec04 Dec18 Dec19 Dec20
Total Equity
Get a 7-Day Free Trial -0.10 0.13 7.14 7.10 6.91

Easton Pharmaceuticals Quarterly Data
Jun02 Sep02 Dec02 Mar03 Jun03 Sep03 Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec18 Dec19 Dec20 Mar21 Jun21 Sep21
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.10 6.91 6.81 6.73 6.65
EAPH
12GF Score
Easton Pharmaceuticals Inc EAPH
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Easton Pharmaceuticals Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Easton Pharmaceuticals's Total Equity for the fiscal year that ended in Dec. 2020 is calculated as

Total Equity=Total Assets(Q: Dec. 2020 )-Total Liabilities(Q: Dec. 2020 )
=10.192-3.283
=6.91

Easton Pharmaceuticals's Total Equity for the quarter that ended in Sep. 2021 is calculated as

Total Equity=Total Assets(Q: Sep. 2021 )-Total Liabilities(Q: Sep. 2021 )
=9.968-3.32
=6.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $6.65 Mil mean?
Easton Pharmaceuticals (EAPH) has a Total Equity of $6.65 Mil as of Sep. 2021. The total amount of equity as record on a company's balance sheet. View historical data for Easton Pharmaceuticals and its competitors.
Is Easton Pharmaceuticals' Total Equity too high?
Easton Pharmaceuticals' current Total Equity is $6.65 Mil. Overall, Easton Pharmaceuticals has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Easton Pharmaceuticals' Total Equity compare to FPSUF and GCAN?
Easton Pharmaceuticals' Total Equity of $6.65 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Easton Pharmaceuticals and its competitors. Easton Pharmaceuticals's current Total Equity is $6.65 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Easton Pharmaceuticals stock overvalued right now?
Easton Pharmaceuticals (EAPH) has a current Total Equity of $6.65 Mil. The current Total Equity is $6.65 Mil. Easton Pharmaceuticals' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Easton Pharmaceuticals (EAPH), the current Total Equity is $6.65 Mil as of Sep. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Easton Pharmaceuticals Business Description

Address 2 Bloor Street East, Suite 3500, Toronto, ON, CAN, M4W 1A8
Easton Pharmaceuticals Inc is a diversified specialty pharmaceutical company. It owns and develops proprietary transdermal delivery technology and therapeutic over the counter products and drugs to treat cancer and other diseases. The company also owns exclusive distribution rights in Mexico and Latin America for patented women's diagnostic and preventative care products. It is focused on the development of product Viorra. The firm's products include Nauseasol, Skin Renou HA, Kenestrin gel, and XILIVE, among others.
12GF Score

Get the complete analysis for EAPH

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price